46/#972 Prediction of platinum-based chemotherapy resistance in epithelial ovarian cancer using apparent diffusion coefficient of magnetic resonance image and machine learning algorithm. (4th December 2022)
- Record Type:
- Journal Article
- Title:
- 46/#972 Prediction of platinum-based chemotherapy resistance in epithelial ovarian cancer using apparent diffusion coefficient of magnetic resonance image and machine learning algorithm. (4th December 2022)
- Main Title:
- 46/#972 Prediction of platinum-based chemotherapy resistance in epithelial ovarian cancer using apparent diffusion coefficient of magnetic resonance image and machine learning algorithm
- Authors:
- Lee, Sung-Jong
Woo, Jae Yeon
Song, Heekyoung
Cha, Jimin - Abstract:
- Abstract : Objectives: To investigate the role of a preoperative apparent diffusion coefficient (ADC) of magnetic resonance imaging (MRI) and machine learning for the prediction of platinum-based chemotherapy resistance in patients with epithelial ovarian cancer (EOC). Methods: The ADC of MRI was preoperatively evaluated on the largest solid portion of the ovarian mass on the axial MRI maps. All patients underwent platinum-based chemotherapy after cytoreductive surgery. Logistic regression and machine learning applications were used to investigate the role of the ADC and clinical factors for the prediction of platinum-based chemotherapy resistance in ovarian cancer. Results: Of the 168 patients, 97 had high-grade serous ovarian cancer (HGSOC) and 71 had non-HGSOC patients; 33 clear cell carcinoma, 18 mucinous carcinoma, 15 endometrioid carcinoma, 5 low-grade serous carcinoma. The patients were divided into the platinum-sensitive group (n=146) and the platinum-resistance group (n=22). The gradient boosting machine algorithm showed the highest accuracy in differentiating histologic types of ovarian cancers (accuracy: 0.91, AUC: 0.93). In the ROC curve, CA 125 and the ratio of solid to the total area were significantly associated with platinum-based chemotherapy resistance (AUC: 0.758, AUC: 0.687, respectively). The deep learning algorithm demonstrated increased accuracy (AUC: 0.814). In cox regression analysis, the area of the solid portion was significantly related to theAbstract : Objectives: To investigate the role of a preoperative apparent diffusion coefficient (ADC) of magnetic resonance imaging (MRI) and machine learning for the prediction of platinum-based chemotherapy resistance in patients with epithelial ovarian cancer (EOC). Methods: The ADC of MRI was preoperatively evaluated on the largest solid portion of the ovarian mass on the axial MRI maps. All patients underwent platinum-based chemotherapy after cytoreductive surgery. Logistic regression and machine learning applications were used to investigate the role of the ADC and clinical factors for the prediction of platinum-based chemotherapy resistance in ovarian cancer. Results: Of the 168 patients, 97 had high-grade serous ovarian cancer (HGSOC) and 71 had non-HGSOC patients; 33 clear cell carcinoma, 18 mucinous carcinoma, 15 endometrioid carcinoma, 5 low-grade serous carcinoma. The patients were divided into the platinum-sensitive group (n=146) and the platinum-resistance group (n=22). The gradient boosting machine algorithm showed the highest accuracy in differentiating histologic types of ovarian cancers (accuracy: 0.91, AUC: 0.93). In the ROC curve, CA 125 and the ratio of solid to the total area were significantly associated with platinum-based chemotherapy resistance (AUC: 0.758, AUC: 0.687, respectively). The deep learning algorithm demonstrated increased accuracy (AUC: 0.814). In cox regression analysis, the area of the solid portion was significantly related to the resistance to chemotherapy (hazard ratio: 1.033, p=0.014). Conclusions: The ADC and area of the solid portion on MRI using machine learning can be helpful to predict histologic types and resistance of platinum-based chemotherapy in EOC. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 3
- Issue Display:
- Volume 32, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 3
- Issue Sort Value:
- 2022-0032-0003-0000
- Page Start:
- A47
- Page End:
- A47
- Publication Date:
- 2022-12-04
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-igcs.90 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24964.xml